Dental follicle mesenchymal stem cells down-regulate Th2-mediated immune response in asthmatic patients mononuclear cells.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, cilt.48, sa.6, ss.663-678, 2018 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 48 Sayı: 6
- Basım Tarihi: 2018
- Doi Numarası: 10.1111/cea.13126
- Dergi Adı: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.663-678
- Anahtar Kelimeler: asthma, dental follicle mesenchymal stem cells, house dust mite, immunomodulation, T-CELLS, IMMUNOMODULATION, IMMUNOTHERAPY, PHENOTYPES, ALLERGY, CD86
- Marmara Üniversitesi Adresli: Evet
Özet
BackgroundAsthma is a chronic inflammatory disease in which inflammatory responses have the polarisation of CD4(+) T cells to Th2 cells. Dental follicle mesenchymal stem cells (DFSCs) have strong anti-inflammatory properties comparable to other mesenchymal stem cells.